Literature DB >> 35332113

Metabolic Syndrome: A Warning Sign of Liver Fibrosis.

Ji A Seo1.   

Abstract

Entities:  

Year:  2022        PMID： 35332113      PMCID： PMC8987450          DOI： 10.7570/jomes22023

Source DB:  PubMed          Journal:  J Obes Metab Syndr        ISSN： 2508-6235


× No keyword cloud information.
  20 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

2.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  J Hepatol       Date:  2016-04-07       Impact factor: 25.083

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.

Authors:  Vincent Wai-Sun Wong; Wah-Kheong Chan; Shiv Chitturi; Yogesh Chawla; Yock Young Dan; Ajay Duseja; Jiangao Fan; Khean-Lee Goh; Masahide Hamaguchi; Etsuko Hashimoto; Seung Up Kim; Laurentius Adrianto Lesmana; Yu-Cheng Lin; Chun-Jen Liu; Yen-Hsuan Ni; Jose Sollano; Simon Kin-Hung Wong; Grace Lai-Hung Wong; Henry Lik-Yuen Chan; Geoff Farrell
Journal:  J Gastroenterol Hepatol       Date:  2018-01       Impact factor: 4.029

Review 5.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 6.  Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease.

Authors:  Soo Lim; Jin-Wook Kim; Giovanni Targher
Journal:  Trends Endocrinol Metab       Date:  2021-05-08       Impact factor: 12.015

Review 7.  Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.

Authors:  Byung Wan Lee; Yong Ho Lee; Cheol Young Park; Eun Jung Rhee; Won Young Lee; Nan Hee Kim; Kyung Mook Choi; Keun Gyu Park; Yeon Kyung Choi; Bong Soo Cha; Dae Ho Lee
Journal:  Diabetes Metab J       Date:  2020-05-11       Impact factor: 5.376

8.  Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.

Authors:  Robert J Wong; Tram Tran; Harvey Kaufman; Justin Niles; Robert Gish
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

9.  Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study.

Authors:  Eun-Hee Nah; Seon Cho; Suyoung Kim; Jieun Chu; Eunjoo Kwon; Han-Ik Cho
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

Review 10.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30
View more
  1 in total

1.  Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus.

Authors:  Ovidiu Paul Calapod; Andreea Maria Marin; Anca Pantea Stoian; Carmen Fierbinteanu-Braticevici
Journal:  Diagnostics (Basel)       Date:  2022-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.